NIH-funded research NIH-funded research

Understanding how blood production adapts during emergencies

Official title: Emergency Myelopoiesis in the Control of Blood Production

Funded at Columbia University Health Sciences · NIH-11042708 · Data updated 2026-11-12

This study is looking at how your body makes blood cells when it needs them most, like during inflammation or cancer, and it’s for anyone interested in understanding how these processes work and what they mean for health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2024
Project endMarch 31, 2031
Funding year2025
Award (this year)$1,008,571
NIH project number5R35HL171521-02
Project IDNIH-11042708 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with blood disorders, chronic inflammation, or cancers that affect blood cell production.

Less likely to help

Patients with stable blood conditions or those not experiencing any blood-related issues may not benefit from this research.

What this research studies

This research investigates how the body produces blood cells in response to various demands, particularly during emergencies like inflammation or cancer. It focuses on the role of hematopoietic stem cells and progenitor cells in the bone marrow, examining how they respond to signals from their environment to increase blood cell production. The study aims to uncover the mechanisms behind emergency myelopoiesis, which can lead to overproduction of certain blood cells in chronic conditions. By developing a novel platform to model these interactions, the research seeks to enhance our understanding of blood cell formation and its implications for health.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for blood disorders and cancers by optimizing blood cell production.

How similar studies have gone: Previous research has shown promise in understanding blood cell production mechanisms, making this approach a continuation of established findings rather than entirely novel.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Passegue, Emmanuelle — Columbia University Health Sciences
  • Study coordinator: Passegue, Emmanuelle

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.